Phillip Chan
Vermögen: 856 516 $ am 31.05.2026
Vermögen: 856 516 $ am 31.05.2026
Phillip P.
Chan was the founder of Andrew Technologies LLC, founded in 2006, where the title held was Director from 2010 to 2011.
Dr. Chan is the founder of CytoSorbents Europe GmbH, founded in 2012, holding the title of Co-Managing Director since 2012.
Dr. Chan currently works at CytoSorbents Corp.
as Chief Executive Officer & Director since 2020, with employment starting in 2008.
Formerly, Dr. Chan was a Partner at Tech Council Ventures LLC.
Education includes undergraduate studies at Cornell University and a doctorate from Yale School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYTOSORBENTS CORPORATION 2,78 % | 15.06.2026 | 1.744.432 ( 2,78 % ) | 856 516 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOSORBENTS CORPORATION | Vorstandsvorsitzender | 24.07.2008 |
CytoSorbents Europe GmbH
CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Vorstandsvorsitzender | 01.02.2012 |
| Unternehmen | Position | Ende |
|---|---|---|
Tech Council Ventures LLC
Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses on the board range of sector and industries . It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. It takes board seat and acts as lead investor. | Private Equity Investor | 30.06.2009 |
Andrew Technologies LLC
Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Tech Council Ventures LLC
Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses on the board range of sector and industries . It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. It takes board seat and acts as lead investor. | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
Andrew Technologies LLC
Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Health Technology |
CytoSorbents Europe GmbH
CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Distribution Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen